DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMLAMSRAFoundation

Neurological complications of nutritional deficiency

Recognise deficiency-related neuropathy, myelopathy, ataxia and encephalopathy, identify malabsorption and functional deficiency, and replace nutrients urgently without masking a second diagnosis or causing refeeding harm.

Open the sections you need. The overview is shown first.
01OverviewDefinition, clinical context and the essential points that orientate the chapter.

The nervous system depends on micronutrients for myelin, mitochondrial energy, neurotransmission and antioxidant defence. Deficiency therefore produces overlapping patterns rather than one symptom per vitamin. Tempo, diet, gastrointestinal anatomy, alcohol, medicines, recreational exposure and systemic clues identify the likely mechanism. Ask about bariatric or gastric surgery, ileal disease, coeliac disease, chronic diarrhoea, pancreatic or cholestatic disease, vegan diet, food insecurity, eating disorder, alcohol dependence, nitrous oxide and zinc-containing supplements or denture products.

B12 and copper deficiency both damage posterior columns and corticospinal tracts, causing impaired vibration and joint position, sensory ataxia, paraesthesia and spastic weakness. B12 can also cause neuropathy, optic disease and neuropsychiatric manifestations. Thiamine deficiency is an emergency when encephalopathy, eye signs or gait ataxia occurs. Vitamin E deficiency resembles a hereditary ataxia with large-fibre neuropathy. Niacin deficiency causes pellagra—photosensitive dermatitis, diarrhoea and cognitive or encephalopathic change—while folate deficiency more often produces haematological and fetal-neural-tube consequences than the classic B12 myelopathy.

Investigations should be obtained before replacement when this does not delay emergency treatment. A serum nutrient result must be interpreted with inflammation, supplementation and functional markers. Treatment includes an adequate loading route, correction of the cause, monitoring of clinical response and a maintenance plan. Neurological recovery is slower than haematological correction and can remain incomplete after prolonged deficiency. Failure to improve should trigger reassessment for compression, inflammation, genetic disease or more than one deficiency rather than endless supplement escalation.

Key points

  • Vitamin B12 deficiency can cause peripheral neuropathy, optic neuropathy, cognitive or psychiatric change and subacute combined degeneration, sometimes with a normal haemoglobin and mean cell volume.
  • Posterior-column sensory loss plus corticospinal signs suggests B12 or copper-related myelopathy; a clear sensory level, sphincter dysfunction or rapid progression still requires urgent spinal imaging.
  • Thiamine deficiency causes Wernicke encephalopathy, painful or weak neuropathy and cardiovascular beriberi; treat suspected neurological deficiency parenterally before or alongside carbohydrate when feasible rather than awaiting a blood concentration, without delaying emergency glucose.
  • Vitamin E deficiency produces a spinocerebellar and large-fibre sensory syndrome with areflexia, dysarthria and sometimes retinopathy, especially after fat malabsorption or in inherited transport disease.
  • Copper deficiency can mimic B12 disease after upper gastrointestinal surgery or excessive zinc exposure and may coexist with anaemia, neutropenia and peripheral neuropathy.
  • Both pyridoxine deficiency and excessive long-term vitamin B6 supplementation can injure peripheral nerves, so supplement dose and duration belong in the exposure history.
  • Nitrous oxide oxidises cobalamin and can cause functional B12 inactivation with myeloneuropathy even when a measured serum B12 concentration appears non-low.
  • Severe malnutrition creates refeeding risk: replace urgent thiamine and correct electrolytes with a controlled nutrition plan rather than delivering unrestricted calories and fluid.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
01

Inadequate intake

Malnutrition, alcohol dependence, restrictive diets, starvation and prolonged vomiting can deplete thiamine, cobalamin and other nutrients essential to neural function.

02

Malabsorption and surgery

Coeliac or ileal disease, pancreatic or fat malabsorption and bariatric or gastric surgery impair uptake of specific vitamins, copper and trace nutrients.

03

Medicine and functional inactivation

Metformin, acid suppression, excessive zinc and recreational nitrous oxide can reduce absorption, deplete copper or inactivate cobalamin despite misleading routine concentrations.

04

Increased requirement and refeeding

Acute illness, pregnancy and nutritional restoration increase cofactor and electrolyte demand, exposing marginal reserves and creating refeeding risk.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
  1. 1
    Cofactor depletion

    Loss of vitamins or trace elements impairs enzymatic reactions needed for energy metabolism, methylation, antioxidant defence and neurotransmission.

  2. 2
    Myelin and axonal injury

    Defective maintenance damages dorsal columns, corticospinal tracts, peripheral nerves and optic pathways in characteristic but overlapping patterns.

  3. 3
    Cellular energy failure

    Severe thiamine deficiency impairs glucose metabolism in vulnerable brain regions, causing oedema, haemorrhagic change and acute encephalopathy.

  4. 4
    Irreversible tissue loss

    Continuing deficiency converts functional metabolic disturbance into neuronal death, demyelination and fixed neurological disability when treatment is delayed.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
B12 myeloneuropathy

Symmetric paraesthesia, impaired vibration and joint position, sensory ataxia, extensor plantar responses and cognitive or optic symptoms may occur without macrocytic anaemia.

Thiamine neurological spectrum

Confusion, ocular motor abnormality and gait dysfunction suggest Wernicke disease, while painful distal neuropathy, weakness and areflexia suggest dry beriberi.

Vitamin E phenotype

Progressive gait and limb ataxia with areflexia, loss of proprioception, dysarthria and possible pigmentary retinopathy follows severe fat-soluble-vitamin deficiency.

Copper myelopathy

A spastic sensory gait with posterior-column loss after gastric surgery or high zinc exposure, especially with neutropenia or anaemia, suggests low copper.

Pyridoxine toxicity

Progressive sensory neuronopathy and ataxia can follow high-dose vitamin B6 supplements, energy products or long-term self-treatment despite their vitamin label.

Pellagra pattern

Photosensitive dermatitis, diarrhoea and cognitive or encephalopathic change in malnutrition or malabsorption raises niacin or tryptophan deficiency.

Refeeding syndrome

Falling phosphate, potassium or magnesium with oedema, arrhythmia, weakness, delirium or respiratory failure can follow rapid nutrition in a severely depleted patient.

Red flags requiring action

  • Confusion, eye-movement abnormality or acute ataxia in malnutrition or alcohol dependence requires immediate parenteral thiamine before or alongside planned glucose-containing nutrition, while urgent hypoglycaemia is corrected without delay.
  • A sensory level, new bladder dysfunction, rapidly progressive paraplegia or severe spinal pain needs emergency cord-compression or inflammatory imaging despite a low vitamin result.
  • Breathlessness, oedema, arrhythmia or circulatory failure during refeeding requires immediate electrolyte, cardiac and nutrition-team management.
  • Progressive visual loss with B12 or vitamin E deficiency requires urgent ophthalmic and neurological assessment because delayed axonal injury may be irreversible.
  • A patient continuing nitrous oxide exposure or high-dose pyridoxine while receiving replacement will continue to accumulate neurological injury.
05InvestigationsWhat to request, why it matters and how to interpret it.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Total or active vitamin B12First step
    Why
    Identify confirmed or indeterminate B12 status using the current NICE diagnostic thresholds and clinical context.
    Interpretation and limitations
    Supplementation can raise the measured value, and nitrous oxide causes functional inactivation; do not delay treatment in severe neurological disease while resolving uncertainty.
  2. 02
    Methylmalonic acid and homocysteine
    Why
    Support functional B12 deficiency when the initial concentration is indeterminate or exposure makes interpretation difficult.
    Interpretation and limitations
    Methylmalonic acid rises with renal impairment and homocysteine also rises in folate deficiency; use laboratory reference ranges and the whole phenotype.
  3. 03
    Full blood count and blood film
    Why
    Detect macrocytosis, pancytopenia, hypersegmented neutrophils, anaemia or copper-associated neutropenia.
    Interpretation and limitations
    Normal indices do not exclude neurological B12 disease, while iron deficiency or inflammation can conceal macrocytosis.
  4. 04
    Copper, caeruloplasmin and zinc
    Why
    Assess copper deficiency and zinc excess in a compatible myeloneuropathy, cytopenia or postoperative setting.
    Interpretation and limitations
    Inflammation and oestrogen can alter caeruloplasmin; interpret concentrations together and identify supplements or denture products driving zinc exposure.
  5. 05
    Vitamin E with lipid context
    Why
    Diagnose fat-soluble antioxidant deficiency in progressive ataxia, neuropathy or malabsorption.
    Interpretation and limitations
    Absolute vitamin E can track circulating lipids, so a vitamin E-to-lipid assessment or specialist interpretation may better identify true tissue deficiency.
  6. 06
    Refeeding biochemical profile
    Why
    Identify phosphate, potassium, magnesium, glucose and fluid disturbance before and during nutrition restoration.
    Interpretation and limitations
    A normal baseline does not eliminate risk because intracellular shifts develop after feeding; monitor at the frequency in the nutrition-support plan.
  7. 07
    Cause investigation
    Why
    Identify autoimmune gastritis, coeliac disease, malabsorption, pancreatic or biliary disease, dietary restriction, surgery or medicine effects.
    Interpretation and limitations
    Intrinsic-factor antibody supports autoimmune gastritis but a negative result does not exclude it; select further tests from NICE guidance and history.
  8. 08
    MRI spinal cord and brain
    Why
    Exclude compression and identify posterior-column or cerebellar changes when deficits are substantial or atypical.
    Interpretation and limitations
    Symmetric posterior-column signal supports a metabolic myelopathy but is not unique to one nutrient and can be normal despite clinical disease.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
01

Inflammatory or compressive myelopathy

A sensory level, rapid progression or sphincter dysfunction requires urgent spinal imaging rather than assumption that a nutritional history explains cord signs.

02

Inherited or degenerative ataxia

A long family pattern and steady progression may indicate genetic disease, but treatable nutritional causes still require targeted exclusion.

03

Toxic neuropathy

Chemotherapy, alcohol and other toxins can produce similar axonal patterns and may coexist with poor nutrition.

04

Infection or encephalitis

Fever, cerebrospinal-fluid inflammation and focal brain imaging support infection, while Wernicke encephalopathy remains a clinical treatment emergency in parallel.

07ManagementImmediate care, first-line treatment, alternatives and escalation.
01B12Neurological B12 deficiencyFirst stepParaesthesia, sensory ataxia, myelopathy, optic or cognitive symptoms occur with confirmed or strongly suspected B12 deficiency.
  1. 1Take total or active B12, full blood count and cause-directed samples before treatment when this creates no harmful delay and document supplements and nitrous oxide.
  2. 2Start intramuscular hydroxocobalamin promptly for significant neurological disease using the BNF or local loading regimen and do not wait for macrocytosis.
  3. 3Investigate autoimmune gastritis, diet, coeliac or ileal disease, medicines and surgery and stop nitrous oxide exposure.
  4. 4Follow neurological response over months and provide lifelong maintenance when an irreversible malabsorption cause requires it.
02POSTOPAtaxia after gastrointestinal surgeryNeuropathy, gait dysfunction or cognitive change follows bariatric, gastric or intestinal surgery.
  1. 1Assess intake, vomiting, weight trajectory, adherence to supplements and the exact surgical anatomy and seek urgent bariatric or nutrition input.
  2. 2Treat possible thiamine deficiency immediately and test B12, folate, copper, zinc, vitamin E and relevant refeeding electrolytes.
  3. 3Image urgently if a sensory level, sphincter sign or rapid focal progression suggests compression rather than nutritional disease.
  4. 4Replace confirmed combined deficiencies with specialist dosing and build a durable surveillance and supplement-access plan.
03COPPERB12-like syndrome with normal B12Posterior-column and corticospinal dysfunction persists despite adequate B12 status or replacement.
  1. 1Review gastric surgery, malabsorption and all zinc-containing products and check copper, caeruloplasmin, zinc and full blood count.
  2. 2Stop unnecessary zinc and refer neurology and nutrition or gastroenterology for oral or intravenous copper selection according to severity and absorption.
  3. 3Monitor blood count and copper response while continuing to exclude structural cord disease and coexisting B12 or vitamin E deficiency.
  4. 4Explain that haematological recovery may precede neurological improvement and established disability may not reverse fully.
04REFEEDSevere malnutritionLow body mass, major recent weight loss, negligible intake or low electrolytes creates high refeeding risk.
  1. 1Identify risk before feeding and involve dietetics or a nutrition-support team while obtaining phosphate, potassium, magnesium, glucose and fluid status.
  2. 2Give thiamine and other required vitamins before and during nutrition initiation and replace electrolytes according to the local protocol.
  3. 3Start energy and fluid cautiously at the risk-appropriate level and increase under clinical and biochemical monitoring.
  4. 4Respond immediately to oedema, arrhythmia, weakness, delirium or respiratory decline and reassess the feeding rate and electrolyte replacement.
Key medicines and prescribing safety4 treatments · regimens, roles and cautions
Restores cobalamin for myelin and cellular metabolism and prevents further progression of B12-related neuropathy or myelopathy.

Hydroxocobalamin

For B12 deficiency with neurological involvement, give 1 mg intramuscularly on alternate days until no further improvement, then use the cause-appropriate maintenance schedule, commonly 1 mg every 2 months for irreversible malabsorption.

Do not delay for anaemia, monitor clinical response and potassium when severely depleted, and distinguish lack of response from an incorrect diagnosis or continuing nitrous oxide.

Corrects folate-deficient megaloblastic haematopoiesis and replenishes stores while the dietary or malabsorptive cause is treated.

Folic acid

For confirmed folate deficiency, a common adult regimen is 5 mg orally once daily for 4 months, with longer treatment when the cause persists under specialist guidance.

Exclude or treat B12 deficiency first because folate may correct anaemia while B12-related neurological injury progresses; review interacting antiseizure medicines.

Corrects copper-dependent myelopathy, neuropathy and cytopenia after surgery, malabsorption or zinc excess.

Copper replacement

Use specialist-prescribed oral copper for stable absorptive capacity or intravenous copper for severe deficiency or malabsorption, with dose adjusted to concentrations and clinical response.

Stop the driver, especially unnecessary zinc, and monitor copper, zinc, liver function and blood count; excessive replacement is toxic and neurological recovery may be incomplete.

Prevents further oxidative neurological injury and may improve ataxia or neuropathy in severe vitamin E deficiency.

Vitamin E replacement

Give specialist high-dose oral alpha-tocopherol based on the confirmed deficiency, weight, underlying transport or malabsorption disorder and serial vitamin E response.

Use a regulated preparation, monitor bleeding with anticoagulants and interpret levels with lipids; generic supplementation is not treatment for every ataxia.

08ComplicationsImportant consequences, why they occur and why they matter clinically.
01

Permanent gait and sensory disability

Delayed replacement can leave spasticity, ataxia, foot injury and dependence because lost axons do not reliably regenerate.

02

Cognitive and visual loss

Thiamine, cobalamin and other deficiencies may cause persistent amnesia, optic neuropathy and impaired capacity or communication.

03

Refeeding syndrome

Rapid nutrition after severe depletion shifts phosphate, potassium and fluid, causing arrhythmia, respiratory failure, seizures and death.

04

Aspiration, falls and pressure injury

Weakness, encephalopathy and ataxia increase pneumonia, fractures, skin injury and rehabilitation needs during recovery after severe deficiency.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.
  • Document vibration, joint position, reflexes, plantar responses, gait, pain, vision and cognition at baseline so slow neurological response can be judged.
  • Repeat the nutrient or functional marker at the NICE or specialist interval and avoid frequent testing that does not alter loading treatment.
  • Follow full blood count and reticulocyte response when cytopenia is present, recognising that neurological recovery follows a different timeline.
  • Monitor phosphate, potassium, magnesium, glucose, fluid balance and weight closely during refeeding according to initial risk.
  • Confirm that nitrous oxide, excessive zinc or pyridoxine exposure has stopped rather than counteracting it with escalating replacement.
  • Review adherence, formulation and access after bariatric surgery or malabsorption and assign long-term monitoring responsibility.
  • Reassess the diagnosis and obtain imaging or neurophysiology when deterioration continues despite adequate biochemical correction.
10Special situationsVariants, exceptions and circumstances that change the usual approach.

Normal blood count can mislead

Neurological B12 disease can precede or occur without anaemia and macrocytosis, so symptoms and risk factors must shape testing and treatment.

Nitrous oxide is functional deficiency

Oxidation inactivates cobalamin-dependent enzymes, meaning a stored serum concentration may not reflect usable intracellular B12.

Copper resembles B12

Both deficiencies affect posterior columns and corticospinal tracts, and both may coexist after complex gastrointestinal surgery.

Vitamin labels do not guarantee safety

Long-term high pyridoxine intake can cause disabling sensory neuronopathy, making supplement reconciliation clinically important.

Response is compartment specific

Anaemia and neutropenia may normalise before axons recover, so an early blood response does not establish full neurological reversibility.

Refeeding shifts are intracellular

Insulin-driven uptake can cause dangerous phosphate, potassium and magnesium falls only after nutrition begins despite acceptable baseline values.

11Common pitfallsFrequent interpretation and management errors.
  1. 01

    Do not exclude B12 neurological disease because haemoglobin and mean cell volume are normal.

  2. 02

    Do not give folic acid alone before considering B12 deficiency in a patient with macrocytosis or neurological symptoms.

  3. 03

    Do not delay parenteral thiamine for a laboratory assay in a high-risk encephalopathic or ataxic patient.

  4. 04

    Do not attribute a sensory level or sphincter dysfunction to vitamin deficiency without urgent spinal cord imaging.

  5. 05

    Do not forget copper and zinc after gastric surgery when B12 replacement fails to explain progression.

  6. 06

    Do not prescribe unrestricted calories to a severely malnourished patient without a refeeding prevention and monitoring plan.

  7. 07

    Do not continue high-dose over-the-counter pyridoxine or nitrous oxide while investigating a progressive sensory neuropathy.

Practice

Two practice questions

Question 1 of 20 correct
NeurologyOriginal SBA

Neurological B12 despite normal indices

A patient has progressive paraesthesia, impaired joint position and extensor plantar responses. Haemoglobin and mean cell volume are normal, but vitamin B12 is clearly deficient. What is the best interpretation and treatment?

Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom